纳米载体
医学
癌症
癌症治疗
癌症免疫疗法
免疫疗法
药物输送
靶向治疗
癌症治疗
靶向给药
纳米技术
药品
药理学
内科学
材料科学
作者
Dhvani H. Kuntawala,Zaib Hussain
标识
DOI:10.1007/978-981-99-6940-1_1
摘要
Cancer remains a global leading cause of death and is a complex disease that needs a versatile method to treat. Despite strategies to reduce deaths, alleviate chronic pain, and improve quality of life, existing shortfalls in cancer therapies still face limitations. The use of nanotechnology has developed as a promising avenue in cancer treatment, specifically nanoparticles (NPs) ranging from 1 to 100 nm. The design of these NPs plays an important role since physical and structural features control the pharmacokinetics, internalization, and safety of the drugs. Moreover, with the emerging multidrug resistance mechanisms studied, NPs are being subjected to more renewed research. Recently, scientists have started to explore the role of NPs in immunotherapy. Potential advantages of using nanocarriers in different biomedical applications, especially targeted therapy have been extensively studied for cancer treatment. This chapter discusses numerous types of NPs, targeting mechanisms, immunotherapy, and the importance of nanotechnology in cancer treatment. Further, we also summarize the future perspectives. Overall, further research in this area will lead to new innovative methodologies for cancer treatment that can improve patient outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI